Nippon India Pharma Fund(IDCW)
Scheme Returns
-4.56%
Category Returns
-5.96%
Riskometer
- Low
- Low to moderate
- Moderate
- Moderately High
- High
- Very High
NAV Chart
Trailing Returns
| 1 Day | 1 week | 1 Mth | 3 Mth | 1 Yrs | 3 Yrs | 4 Yrs | 5 Yrs | Since Inception | |
| Nippon India Pharma Fund(IDCW) | 0.92 | -1.38 | -4.56 | 0.10 | 35.69 | 18.23 | 21.87 | 27.12 | 20.90 |
| Equity - Sectoral Fund - Pharma & Health Care | 0.57 | -1.26 | -5.96 | -3.45 | 30.97 | 20.53 | 27.89 | 23.93 | 17.67 |
* Equity - Returns upto 1 year are absolute and over 1 year are CAGR.
* Debt - Returns upto 1 year are annualized and over 1 year are CAGR.
-
AMC
Nippon Life India Asset Management Limited
-
Fund
Nippon India Mutual Fund
Snapshot
-
Inception Date
05-Jun-2004
-
Initial Price
₹10
-
Entry Load
--
-
Size of Fund(in Cr.)
20,084.63
-
Scheme Plan
--
-
Scheme Class
Equity - Sectoral Fund - Pharma & Health Care
-
Objectives
The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities of Pharma and other associated companies
-
Scheme Type
Open ended scheme
-
Min. Investment
₹5,000
-
Exit Load
1
-
Latest NAV
127.5254
-
Fund Manager
Mr. Sailesh Raj Bhan
-
Fund Manager Profile
Sailesh has Over 10 years experience in Equity Securities research and analysis. he is in Reliance Capital Asset Management Limited as managing various Schemes of Reliance Mutual Fund From 2003 to till date
-
Fund Information
-
AMC
Nippon Life India Asset Management Limited
-
Address
4th Floor, Tower A, Peninsula Business Park, Ganapatrao Kadam Marg, Lower Parel (W) Mumbai - 400 013
-
Phone
022-68087000
-
Fax
022-68087097
-
Email
customercare@nipponindiaim.in
-
Website
https://mf.nipponindiaim.com/
-
Registrar Agent
-
Registrar
KFin Technologies Limited
-
Address
Selenium Building, Tower-B, Plot No 31 & 32 Financial District,Nanakramguda, Serilingampally Hyderabad - 500 032
-
Phone
(040) 23312454 23320751 23320752
-
Fax
(040) 23311968
-
Email
customercare@karvy.com
-
Website
https://mfs.kfintech.com/
Portfolio Details
Companies - Holding Percentage
| Company | Market Value | hold percentage |
|---|---|---|
| Sun Pharmaceutical Industries Limited | 121220.34 | 13.95 |
| Divi's Laboratories Limited | 79557.86 | 9.16 |
| Lupin Limited | 70062.79 | 8.06 |
| Cipla Limited | 48104.25 | 5.54 |
| Apollo Hospitals Enterprise Limited | 45562.93 | 5.24 |
| Dr. Reddy's Laboratories Limited | 44598.91 | 5.13 |
| Triparty Repo | 38563.96 | 4.44 |
| Vijaya Diagnostic Centre Limited | 30230.62 | 3.48 |
| Ajanta Pharma Limited | 29400.37 | 3.38 |
| JB Chemicals & Pharmaceuticals Limited | 25078.18 | 2.89 |
| Abbott India Limited | 25034.7 | 2.88 |
| Gland Pharma Limited | 24766.5 | 2.85 |
| Mankind Pharma Limited | 24027.33 | 2.77 |
| Aurobindo Pharma Limited | 23777.23 | 2.74 |
| GlaxoSmithKline Pharmaceuticals Limited | 22587.27 | 2.6 |
| MedPlus Health Services Limited | 20516.33 | 2.36 |
| Zydus Lifesciences Limited | 20031.33 | 2.31 |
| Narayana Hrudayalaya Limited | 19107.58 | 2.2 |
| Thyrocare Technologies Limited | 16514.12 | 1.9 |
| Pfizer Limited | 16224.02 | 1.87 |
| Torrent Pharmaceuticals Limited | 16120.99 | 1.86 |
| Alkem Laboratories Limited | 16032.33 | 1.85 |
| Sanofi India Limited | 15645.37 | 1.8 |
| Fortis Healthcare Limited | 14368.1 | 1.65 |
| Sanofi Consumer Healthcare India Limited | 10521.96 | 1.21 |
| Syngene International Limited | 9676.05 | 1.11 |
| Orchid Pharma Limited | 9082.87 | 1.05 |
| Dr. Lal Path Labs Limited | 9000.06 | 1.04 |
| Indoco Remedies Limited | 5695.6 | 0.66 |
| AstraZeneca Pharma India Limited | 4885.88 | 0.56 |
| Emcure Pharmaceuticals Limited | 4317.3 | 0.5 |
| Healthcare Global Enterprises Limited | 4051.04 | 0.47 |
| Krishna Institute Of Medical Sciences Limited | 2516.27 | 0.29 |
| Concord Biotech Limited | 2045.14 | 0.24 |
| Cash Margin - CCIL | 209.88 | 0.02 |
| Net Current Assets | -270.88 | -0.03 |
Sectors - Holding Percentage
| Sector | hold percentage |
|---|---|
| Healthcare | 94.45% |
| Miscellaneous | 4.44% |
| Business Services | 1.11% |
Divident Details
| Scheme Name | Date | Dividend (%) |
| Nippon India Pharma Fund | 05-03-2018 | 6 |
| Nippon India Pharma Fund | 05-03-2019 | 5 |
| Nippon India Pharma Fund | 02-03-2020 | 4.5 |
| Nippon India Pharma Fund | 01-03-2021 | 6 |
| Nippon India Pharma Fund | 28-02-2022 | 3.5 |
| Nippon India Pharma Fund | 26-02-2024 | 10 |
Alternative Funds From Category
| Scheme Name | Asset Size | 1M | 3M | 6M | 1Y | 3Y |
|---|---|---|---|---|---|---|
| UTI Healthcare Fund - Regular Plan - IDCW | 682.85 | -3.43 | 3.44 | 23.56 | 44.48 | 19.66 |
| SBI Healthcare Opportunities Fund - Regular Plan - Income Distribution cum Capital Withdrawal Option (IDCW) | 1637.91 | -2.14 | 4.88 | 18.56 | 43.61 | 22.9 |
| NIPPON INDIA PHARMA FUND - IDCW Option | 200.85 | -4.56 | 0.1 | 14.93 | 35.69 | 18.23 |
Other Funds From - Nippon India Pharma Fund(IDCW)
| Scheme Name | Asset Size | 1M | 3M | 6M | 1Y | 3Y |
|---|---|---|---|---|---|---|
| Nippon India Small Cap Fund - Growth Plan - Growth Option | 62259.56 | -6.6 | -3.54 | 7.08 | 32.49 | 25.97 |
| Nippon India Small Cap Fund - Growth Plan - Growth Option | 61027.03 | -6.6 | -3.54 | 7.08 | 32.49 | 25.97 |
| Nippon India Small Cap Fund - Growth Plan - Growth Option | 60999.55 | -6.6 | -3.54 | 7.08 | 32.49 | 25.97 |
| Nippon India Small Cap Fund - Growth Plan - Growth Option | 60372.55 | -6.6 | -3.54 | 7.08 | 32.49 | 25.97 |
| Nippon India Small Cap Fund - Growth Plan - Growth Option | 56468.75 | -6.6 | -3.54 | 7.08 | 32.49 | 25.97 |
| Nippon India Small Cap Fund - Growth Plan - Growth Option | 51566.11 | -6.6 | -3.54 | 7.08 | 32.49 | 25.97 |
| Nippon India Small Cap Fund - Growth Plan - Growth Option | 50422.78 | -6.6 | -3.54 | 7.08 | 32.49 | 25.97 |
| CPSE ETF | 46793.08 | -8.87 | -14.26 | -0.66 | 54.76 | 43.57 |
| CPSE ETF | 46098.89 | -8.87 | -14.26 | -0.66 | 54.76 | 43.57 |
| Nippon India Small Cap Fund - Growth Plan - Growth Option | 46044.13 | -6.6 | -3.54 | 7.08 | 32.49 | 25.97 |